Neurocognitive Phenotype of Isolated Methylmalonic Acidemia
- 1 June 2012
- journal article
- clinical trial
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 129 (6), e1541-e1551
- https://doi.org/10.1542/peds.2011-1715
Abstract
OBJECTIVE: Methylmalonic acidemia (MMA) is a metabolic disorder with a poorly defined long-term neurocognitive phenotype. We studied the neuropsychological outcomes of patients and examined clinical covariates that influenced cognition. METHODS: A diverse cohort with mut, cblA, or cblB subtypes of isolated MMA (N = 43), ages 2 to 32 years, were evaluated at a single center over a 6-year period. The influence of clinical, laboratory, and metabolic parameters on neuropsychological testing results was determined. RESULTS: Early-onset mut patients (n = 21) manifested the most severe neurocognitive impairments, with a mean ± SD full-scale IQ (FSIQ) of 71.1 ± 14.75. Late-onset mut patients (n = 6) had a mean FSIQ of 88.5 ± 27.62. cblA (n = 7), cblB (n = 6), and mut patients diagnosed prenatally or by newborn screening (n = 3) obtained mean FSIQs in the average range (100.7 ± 10.95, 96.6 ± 10.92, and 106.7 ± 6.66, respectively). Hyperammonemia at diagnosis and the presence of a seizure disorder were associated with a lower FSIQ (P = .001 and P = .041, respectively), but other clinical variables, including basal ganglia injury and mutation status, did not. FSIQ remained stable over longitudinal testing (n = 10). Decreased scores on processing speed, compared with all other intellectual domains, emerged as a specific neurocognitive manifestation. CONCLUSIONS: The neurocognitive outcomes seen in isolated MMA are highly variable. An earlier age of disease onset, the presence of hyperammonemia at diagnosis, and a history of seizures were associated with more severe impairment. In all patient subtypes, selective deficits in processing speed were present.This publication has 34 references indexed in Scilit:
- Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parametersJournal of Inherited Metabolic Disease, 2009
- The role of the basal ganglia in data processingMedical Hypotheses, 2008
- ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometryJournal of Inherited Metabolic Disease, 2006
- Methylmalonic and propionic acidurias: Management without or with a few supplements of specific amino acid mixtureJournal of Inherited Metabolic Disease, 2006
- Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemiaThe Journal of Pediatrics, 1994
- Intellectual outcome in children with maple syrup urine diseaseThe Journal of Pediatrics, 1991
- Acute extrapyramidal syndrome in methylmalonic acidemia: “Metabolic stroke” involving the globus pallidusThe Journal of Pediatrics, 1988
- Benign Methylmalonic AciduriaThe New England Journal of Medicine, 1984
- Neurologic Outcome in Children with Inborn Errors of Urea SynthesisThe New England Journal of Medicine, 1984
- The Natural History of the Inherited Methylmalonic AcidemiasThe New England Journal of Medicine, 1983